DNA Nanomaterials for Delivery of Clustered Regularly Interspaced Short Palindromic Repeats/Cas Systems

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein (CRISPR/Cas) system has been exploited as an efficient gene editing tool with precise site specificity and high efficiency; the delivery of the CRISPR/Cas system is critical for the efficacy of therapeutics and remains challenging. DNA nanomaterials are widely utilized as promising delivery carriers for gene agents because of their excellent molecular recognition capabilities, sequence programmability, and biocompatibility. Herein, recent advances in DNA nanomaterials for the delivery of CRISPR/Cas systems are summarized. Based on their construction strategy, DNA nanomaterial‐based carriers are categorized as branched DNA‐based nanostructures or rolling circle amplification (RCA)‐based DNA nanostructures. Representative studies on the design of DNA nanomaterials as CRISPR/Cas system delivery carriers are highlighted. The current challenges and opportunities for the development of DNA nanomaterials for the delivery of CRISPR/Cas systems are also discussed. It is envisioned that with the development of DNA nanotechnology, DNA nanomaterials will open up new possibilities for CRISPR/Cas‐based therapeutics.

Keywords

• CRISPR/Cas9
• DNA nanomaterials
• DNA nanotechnology
• drug delivery